Undifferentiated MSCs are able to myelinate DRG neuron processes through p75.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Experimental Cell Research

• Publication date

  2013-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexcr.2013.08.016PMID 23973667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease

  2011cited by this paper
• Mesenchymal stem cells support dorsal root ganglion neurons survival by inhibiting the metalloproteinase pathway.

  2011cited by this paper
• Neurotrophin receptors TrkB.T1 and p75NTR cooperate in modulating both functional and structural plasticity in mature hippocampal neurons

  2010cited by this paper
• Future neuroprotective strategies.

  2010cited by this paper
• Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.

  2010cited by this paper
• A long-term observation of olfactory ensheathing cells transplantation to repair white matter and functional recovery in a focal ischemia model in rat.

  2010cited by this paper
• Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression

  2009cited by this paper
• In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.

  2009cited by this paper
• Promoting Axonal Myelination for Improving Neurological Recovery in Spinal Cord Injury

  2009cited by this paper
• Cellular remyelinating therapy in multiple sclerosis.

  2009cited by this paper
• Regeneration and repair in multiple sclerosis: the role of cell transplantation.

  2009cited by this paper
• Long-Lasting Benefits after Treatment of Traumatic Brain Injury (TBI) in Rats with Combination Therapy of Marrow Stromal Cells (MSCs) and Simvastatin

  2008cited by this paper
• MAPKs as mediators of cell fate determination: an approach to neurodegenerative diseases.

  2008cited by this paper
• Dorsal root ganglion neurons induce transdifferentiation of mesenchymal stem cells along a Schwann cell lineage.

  2008cited by this paper
• Mesenchymal stem cells cultured on a collagen scaffold: In vitro osteogenic differentiation.

  2007cited by this paper
• The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.

  2006cited by this paper
• Peripheral Myelin Maintenance Is a Dynamic Process Requiring Constant Krox20 Expression

  2006cited by this paper
• The Polarity Protein Par-3 Directly Interacts with p75NTR to Regulate Myelination

  2006cited by this paper
• Transdifferentiated Mesenchymal Stem Cells as Alternative Therapy in Supporting Nerve Regeneration and Myelination

  2006cited by this paper
• Knockout of p75NTR impairs re‐myelination of injured sciatic nerve in mice

  2006cited by this paper
• Adult mesenchymal stem cells rescue dorsal root ganglia neurons from dying.

  2006cited by this paper
• Differential effects of endogenous brain-derived neurotrophic factor on the survival of axotomized sensory neurons in dorsal root ganglia: a possible role for the p75 neurotrophin receptor.

  2005cited by this paper
• Axonal signals in central nervous system myelination, demyelination and remyelination.

  2005cited by this paper
• The p75 neurotrophin receptor: multiple interactors and numerous functions.

  2004cited by this paper
• Peripheral nerve regeneration by transplantation of bone marrow stromal cell-derived Schwann cells in adult rats.

  2004cited by this paper
• BDNF overexpression produces a long‐term increase in myelin formation in the peripheral nervous system

  2004cited by this paper
• Cortical Microinfarcts and Demyelination Significantly Affect Cognition in Brain Aging

  2004cited by this paper
• Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration.

  2004cited by this paper
• Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro

  2004cited by this paper
• Current approved options for treating patients with multiple sclerosis

  2004cited by this paper
• Neurotrophins in myelination: a new role for a puzzling receptor.

  2003cited by this paper
• White matter changes in schizophrenia: evidence for myelin-related dysfunction.

  2003cited by this paper
• Differential cross-regulation of TrkA and TrkC tyrosine kinase receptors with p75

  2003cited by this paper
• Dynamic patterns of BDNF expression in injured sensory neurons: differential modulation by NGF and NT‐3

  2002cited by this paper
• Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury.

  2002cited by this paper
• The Neurotrophin Receptor p75NTR as a Positive Modulator of Myelination

  2002cited by this paper
• Remyelination of the spinal cord following intravenous delivery of bone marrow cells

  2002cited by this paper
• Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone‐marrow stromal cells

  2001cited by this paper
• Inaugural Article: Neurotrophins are key mediators of the myelination program in the peripheral nervous system

  2001cited by this paper
• Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents

  2000cited by this paper
• Schwann cell remyelination is restricted to astrocyte‐deficient areas after transplantation into demyelinated adult rat brain

  2000cited by this paper
• Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system

  1997cited by this paper
• Schwann cell invasion of the central nervous system of the myelin mutants

  1997cited by this paper
• Expression and function of TrkB variants in developing sensory neurons.

  1996cited by this paper
• Timing and Regulation of trkB and BDNF mRNA Expression in Placode‐derived Sensory Neurons and their Targets

  1996cited by this paper
• Naturally Occurring Truncated trkB Receptors Have Dominant Inhibitory Effects on Brain-Derived Neurotrophic Factor Signaling

  1996cited by this paper
• The Use of Transplanted Glial Cells to Reconstruct Glial Environments in the CNS

  1995cited by this paper
• Transplantation of rat Schwann cells grown in tissue culture into the mouse spinal cord.

  1981cited by this paper
• Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve

  1977cited by this paper

• Schwann cell‑derived exosomes induce bone marrow‑derived mesenchymal stem cells to express Schwann cell markers in vitro.

  2020cites this paper
• Cerebrospinal Fluid (CSF) Exchange with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Experimental Autoimmune Encephalomyelitis

  2019cites this paper
• Human bone marrow‐derived MSCs spontaneously express specific Schwann cell markers

  2019cites this paper
• Bioprocess optimisation improves identity and potency of olfactory ensheathing cells for neurologic regeneration

  2018cites this paper
• In vitro enhancement and functional characterization of neurite outgrowth by undifferentiated adipose-derived stem cells.

  2018cites this paper
• Differentiation Potential of Mesenchymal Stem Cells and Stimulation of Nerve Regeneration

  2018cites this paper
• Three kinds of mesenchymal stem cells: differentiating into neuron‐like cells

  2018cites this paper
• Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy

  2017cites this paper
• Bone Marrow-Derived Mesenchymal Stem Cells Improve Diabetic Neuropathy by Direct Modulation of Both Angiogenesis and Myelination in Peripheral Nerves

  2016cites this paper
• Rat mesenchymal stem cells differentiate to endothelial cells after allotransplantation into the damaged nerve

  2016cites this paper
• A Modified Approach to Inducing Bone Marrow Stromal Cells to Differentiate into Cells with Mature Schwann Cell Phenotypes

  2016cites this paper
• Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE

  2015cites this paper